• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Molecular epidemiology and genetic characterization of influenza B virus in Lebanon during 2016-2018

tetano

Editor, Senior Moderator
Infect Genet Evol. 2019 Jul 17:103969. doi: 10.1016/j.meegid.2019.103969. [Epub ahead of print]
[h=1]Molecular epidemiology and genetic characterization of influenza B virus in Lebanon during 2016-2018.[/h] AlIbrahim M[SUP]1[/SUP], Assaf-Casals A[SUP]2[/SUP], Massaad E[SUP]3[/SUP], Shaker R[SUP]2[/SUP], Soudani N[SUP]1[/SUP], Fayad D[SUP]2[/SUP], Chamseddine S[SUP]2[/SUP], Lteif-Khoury M[SUP]2[/SUP], Chmaisse A[SUP]2[/SUP], Isaac I[SUP]2[/SUP], Anan H[SUP]2[/SUP], Sadaka C[SUP]2[/SUP], Radwan N[SUP]2[/SUP], Ghanem S[SUP]4[/SUP], Naous A[SUP]4[/SUP], Karam M[SUP]5[/SUP], Andary R[SUP]6[/SUP], Dbaibo G[SUP]2[/SUP], Zaraket H[SUP]7[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza B viruses are a major cause of serious acute respiratory infections in humans.
[h=4]METHODS:[/h] Nasopharyngeal swabs were collected from subjects with influenza-like illness during October 2016-June 2018 and screened for influenza A and B. The hemagglutinin (HA) and neuraminidase (NA) genes of the Lebanese influenza B specimens were sequenced and phylogenetically compared with the vaccine strains and specimens from the Eastern Mediterranean Region and Europe.
[h=4]RESULTS:[/h] Influenza A and B viruses co-circulated between October and May and peaked between January and March. During the 2016-2017 season, A/H3N2 (33.4%) and B/Yamagata (29.7%) were the predominantly circulating viruses followed by B/Victoria and A/H1N1pdm09 viruses. During the 2017-2018 season, A/H3N2 (31.5%) and A/H1Npdm09 (29.3%) were most prevalent with co-circulation of B/Yamagata and to a lesser extent B/Victoria viruses. The B/Yamagata specimens belonged to clade-3 while the B/Victoria belonged to clade-1A. None of the analyzed specimens had a mutation known to confer resistance to NA inhibitors (NAIs).
[h=4]CONCLUSION:[/h] Multiple subtypes of influenza co-circulate each year in Lebanon with a peak between January and March. The trivalent vaccine included a B/Victoria strain which mismatched the B/Yamagata lineage that predominated during the study period, highlighting the importance of quadrivalent vaccines.
Copyright ? 2018. Published by Elsevier B.V.


[h=4]KEYWORDS:[/h] Influenza; Lebanon; Phylogenetic analysis; Surveillance; Vaccination

PMID: 31325610 DOI: 10.1016/j.meegid.2019.103969
 
Back
Top Bottom